Bio-Connect

HLA-A2 antibody [BB7.2]

GTX75803
GeneTex
ApplicationsFlow Cytometry, ImmunoPrecipitation, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen
Product group Antibodies
TargetHLA-A
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    HLA-A2 antibody [BB7.2]
  • Delivery Days Customer
    9
  • Application Supplier Note
    FACS: 10microg/ml. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    Flow Cytometry, ImmunoPrecipitation, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    BB7.2
  • Concentration
    1 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID3105
  • Target name
    HLA-A
  • Target description
    major histocompatibility complex, class I, A
  • Target synonyms
    HLAA, HLA class I histocompatibility antigen, A alpha chain, HLA class I histocompatibility antigen, A-1 alpha chain, MHC class I antigen HLA-A heavy chain, leukocyte antigen class I-A
  • Host
    Mouse
  • Isotype
    IgG2b
  • Scientific Description
    HLA-A belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen. They are expressed in nearly all cells. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exons 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region, and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. Hundreds of HLA-A alleles have been described. [provided by RefSeq, Jul 2008]
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Repáraz D, Ruiz M, Llopiz D, et al. Neoantigens as potential vaccines in hepatocellular carcinoma. J Immunother Cancer. 2022,10(2). doi: 10.1136/jitc-2021-003978
    Read this paper
  • Bonaventura P, Alcazer V, Mutez V, et al. Identification of shared tumor epitopes from endogenous retroviruses inducing high-avidity cytotoxic T cells for cancer immunotherapy. Sci Adv. 2022,8(4):eabj3671. doi: 10.1126/sciadv.abj3671
    Read this paper
  • Wu L, Zhang H, Jiang Y, et al. Induction of antitumor cytotoxic lymphocytes using engineered human primary blood dendritic cells. Proc Natl Acad Sci U S A. 2018,115(19):E4453-E4462. doi: 10.1073/pnas.1800550115
    Read this paper
  • Chung B, Stuge TB, Murad JP, et al. Antigen-specific inhibition of high-avidity T cell target lysis by low-avidity T cells via trogocytosis. Cell Rep. 2014,8(3):871-882. doi: 10.1016/j.celrep.2014.06.052
    Read this paper
  • Liu B, Zhong S, Malecek K, et al. 2D TCR-pMHC-CD8 kinetics determines T-cell responses in a self-antigen-specific TCR system. Eur J Immunol. 2014,44(1):239-50. doi: 10.1002/eji.201343774
    Read this paper